Corcoran Andrea
SEC insider (Form 3/4/5 filer). CIK 0001296996. Officer at Atea Pharmaceuticals, Inc. (AVIR). 7 reported Form 4/5 transactions since Sep 2024; latest on Mar 11, 2026. Located in BOSTON, MA.
Companies Corcoran Andrea has filed insider reports for
- Atea Pharmaceuticals, Inc. (AVIR): Officer, See Remarks
Corcoran Andrea
CIK: 0001296996
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Atea Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Mar 11, 2026AVIR
Atea Pharmaceuticals, Inc.
ExerciseDirect60K shares at avg. $1.24$74K - Jan 31, 2026AVIR
Atea Pharmaceuticals, Inc.
ExerciseDirect54.9K shares- - Jan 31, 2026AVIR
Atea Pharmaceuticals, Inc.
Tax PaymentDirect16.1K shares at avg. $4.24$68K - Jan 31, 2026AVIR
Atea Pharmaceuticals, Inc.
AwardDirectStock Option (Right to Buy)
180K shares- - Jan 31, 2025AVIR
Atea Pharmaceuticals, Inc.
Tax PaymentDirect16.1K shares at avg. $3.06$49K - Jan 31, 2025AVIR
Atea Pharmaceuticals, Inc.
ExerciseDirect44.4K shares- - Jan 31, 2025AVIR
Atea Pharmaceuticals, Inc.
AwardDirect10.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 11, 2026 | AVIR Atea Pharmaceuticals, Inc. | Exercise | 60,000 | $1.24 | $74,400 | Direct |
| Jan 31, 2026 | AVIR Atea Pharmaceuticals, Inc. | Exercise | 54,866 | - | $0 | Direct |
| Jan 31, 2026 | AVIR Atea Pharmaceuticals, Inc. | Tax Payment | 16,104 | $4.24 | $68,281 | Direct |
| Jan 31, 2026 | AVIR Atea Pharmaceuticals, Inc. | Award Stock Option (Right to Buy) | 180,000 | - | - | Direct |
| Jan 31, 2025 | AVIR Atea Pharmaceuticals, Inc. | Tax Payment | 16,102 | $3.06 | $49,272 | Direct |
| Jan 31, 2025 | AVIR Atea Pharmaceuticals, Inc. | Exercise | 44,367 | - | - | Direct |
| Jan 31, 2025 | AVIR Atea Pharmaceuticals, Inc. | Award | 10,500 | - | - | Direct |
1-7 of 7 transactions